Company Cash Funds: cumberlandpharma.com (CPIX)

Cumberland Pharmaceuticals Inc - graphic logo of issuer CPIX

Cumberland Pharmaceuticals (CPIX) maintains a standard liquidity level, funding current needs through operational cash flow. Growth in government procurement of Vibativ and the expansion of the GI portfolio are driving the business toward profitability. The cash balance on the balance sheet confirms financial stability, with the 0.08 metric serving as the target level. Ownership of niche hospital antidotes guarantees stability, rendering CPIX a defensive asset against market shocks.

Company Cash Funds: Cumberland Pharmaceuticals Inc (CPIX) for 07/04/2022 - 11/21/2026

Cumberland Pharmaceuticals Inc. (CPIX) - metric breakdowns and financial figures

- company stock exchange capitalization indicators:
- cash availability and cash flow indicators:
Summary company analytics:Cumberland Pharmaceuticals CPIX
Signature product of cumberlandpharma.com

This indicator captures the volume of liquid assets available to cover current expenses, allowing for the real-time tracking of cash gap risks regardless of quarterly reporting. A high level of cash on hand confirms the ability of Cumberland Pharmaceuticals (CPIX) experienced management to maintain the margins of niche hospital drugs, ensuring the business's financial stability while optimizing return on assets.

Direct competitors

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|ARS Corp - Company Cash Volume|TBPH: Company Cash Funds|AQST: Company Cash Volume|SCPH - Company Liquid Assets|TECX (Tectonic) - Company Cash Volume|Company Cash Reserve Tonix Pharmaceuticals Holding Corp. TNXP|Company Cash Funds SXT Pharmaceuticals (SXTC)|Company Cash Volume Eupraxia Pharmaceuticals Inc. (EPRX)|Company Cash Funds BioHarvest Sciences BHST|EXOZ (Invizyne) - Company Total Cash Volume|ORMP: Company Cash on Hand|ENTX (Entera Bio Ltd) - Company Cash and Cash Equivalents|HYFT: Company Cash Volume|Company Cash on Hand ABVC BioPharma Inc.|Company Cash Funds Quantum BioPharma Limited|FGEN: Company Cash Balance|Company Cash Volume TELO|Rani Therapeutics Holdings, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Synergy CHC Corp. SNYR|Company Cash Balance RLYB|LEXX: Company Cash on Hand|Company Cash Balance PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Company Cash Funds|Company Cash on Hand Aptorum|Company Cash on Hand LYRA|Impact BioMedical Inc - Company Total Cash Volume|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance